SFA Therapeutics Patents

Patent portfolio assigned to SFA Therapeutics (verified via public assignee records). Estimated patent count: 19. Clinical-stage microbiome-based biopharma (US, YC). Company IP-update press release states 19 issued patents (6 US + 13 foreign) plus 30+ pending applications, so has_patents=true, count ~19. As a clinical-stage drug developer it has no customers; no sourced direct-competitor list.